BioNTech SE (BNTX) Asset Writedowns and Impairment (2018 - 2021)

BioNTech SE (BNTX) has 4 years of Asset Writedowns and Impairment data on file, last reported at $844365.3 in Q1 2021.

• For the quarter ending Q1 2021, Asset Writedowns and Impairment rose 91.22% year-over-year to $844365.3; the trailing twelve-month figure through Mar 2021 stood at -$1.6 million (changed N/A YoY), and the FY2020 full-year result was $2287.0, up 18.93% from the prior year.
• Asset Writedowns and Impairment rose to $844365.3 in Q1 2021, from $441575.6 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $844365.3 in Q1 2021 to a low of -$1.5 million in Q4 2018.
• A 4-year average of -$402109.9 and a median of -$488330.4 in 2020 frame the typical range for Asset Writedowns and Impairment.
• Across the five-year window, Asset Writedowns and Impairment grew 3.92% in 2019 and soared 91.22% in 2021, its largest moves.
• Tracing BNTX's Asset Writedowns and Impairment over 4 years: stood at -$1.5 million in 2018, then rose by 3.92% to -$1.4 million in 2019, then jumped by 131.14% to $441575.6 in 2020, then soared by 91.22% to $844365.3 in 2021.
• Business Quant data shows BNTX's Asset Writedowns and Impairment at $844365.3 in Q1 2021, $441575.6 in Q1 2020, and -$1.4 million in Q4 2019.